Literature DB >> 30217870

High-frequency oscillatory ventilation with volume guarantee: a single-centre experience.

Gusztav Belteki1, Colin J Morley1.   

Abstract

OBJECTIVE: High-frequency oscillatory ventilation (HFOV) is widely used in neonatology. The Dräger Babylog VN500 ventilator offers volume-guaranteed HFOV (HFOV-VG) mode when the high-frequency tidal volume (VThf) to be delivered can be set. We investigated how HFOV-VG maintains VThf in the short and longer term and how it affects other ventilator parameters and blood gases.
METHODS: We downloaded ~3.2 million seconds (36.7 days) of ventilator data from 17 infants ventilated using HFOV-VG during clinical care with 1 Hz sampling rate. To process and analyse the data, we used the Python computer language.
RESULTS: Overall, the median VThf was 1.93 mL/kg (IQR 1.64-2.45 mL/kg). The difference between set and delivered tidal volume was <0.2 mL/kg for 83% of time. In the individual recordings, the median VThf ranged between 1.44 and 3.31 mL/kg. During HFOV-VG, the VThf varied from 1 second to another, but it was very close to the target value when averaged over 5 min periods. After weight correction, the VThf or the diffusion coefficient of carbon dioxide (DCO2) showed weak inverse correlation with partial pressure of CO2(pCO2) (for VThf, r=-0.162, 95% CI -0.282 to -0.037, p=0.01). Uncorrected values showed no correlation. Of the 53 blood gas measurements taken when VThf was >2.5 mL/kg, there were only six (11%) with a pCO2 >8 kPa.
CONCLUSIONS: During HFOV-VG, the tidal volume of oscillations varies in the short term but is maintained very close to the target over the longer term. VThf or DCO2 have poor correlation with CO2 levels but a volume of >2.5 mL/kg VThf is rarely needed. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Hfov; Mechanical Ventilation; Neonatology; Volume-targeted Ventilation

Mesh:

Year:  2018        PMID: 30217870     DOI: 10.1136/archdischild-2018-315490

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  6 in total

1.  Therapeutic effects and outcomes of rescue high-frequency oscillatory ventilation for premature infants with severe refractory respiratory failure.

Authors:  Jen-Fu Hsu; Mei-Chin Yang; Shih-Ming Chu; Lan-Yan Yang; Ming-Chou Chiang; Mei-Yin Lai; Hsuan-Rong Huang; Yu-Bin Pan; Ren-Huei Fu; Ming-Horng Tsai
Journal:  Sci Rep       Date:  2021-04-19       Impact factor: 4.379

2.  The clinical effects of high-frequency oscillatory ventilation in the treatment of neonatal severe meconium aspiration syndrome complicated with severe acute respiratory distress syndrome.

Authors:  Guang Yang; Yunxia Qiao; Xinxin Sun; Tiandan Yang; Aiying Lv; Min Deng
Journal:  BMC Pediatr       Date:  2021-12-10       Impact factor: 2.125

3.  Respiratory and Gastrointestinal Management of an Infant with a Birth Weight of 258 Grams.

Authors:  Ryo Itoshima; Arata Oda; Ryo Ogawa; Toshimitsu Yanagisawa; Takehiko Hiroma; Tomohiko Nakamura
Journal:  AJP Rep       Date:  2021-10-25

4.  Effects of High-Frequency Oscillatory Ventilation With Volume Guarantee During Surfactant Treatment in Extremely Low Gestational Age Newborns With Respiratory Distress Syndrome: An Observational Study.

Authors:  Milena Tana; Angela Paladini; Chiara Tirone; Claudia Aurilia; Alessandra Lio; Anthea Bottoni; Simonetta Costa; Eloisa Tiberi; Roberta Pastorino; Giovanni Vento
Journal:  Front Pediatr       Date:  2022-03-03       Impact factor: 3.418

5.  Effect of a new respiratory care bundle on bronchopulmonary dysplasia in preterm neonates.

Authors:  Cristina Ramos-Navarro; Noelia González-Pacheco; Ana Rodríguez-Sánchez de la Blanca; Manuel Sánchez-Luna
Journal:  Eur J Pediatr       Date:  2020-06-02       Impact factor: 3.183

6.  Volume Guarantee High-Frequency Oscillatory Ventilation in Preterm Infants With RDS: Tidal Volume and DCO2 Levels for Optimal Ventilation Using Open-Lung Strategies.

Authors:  Funda Tuzun; Burak Deliloglu; Merve Meryem Cengiz; Burcin Iscan; Nuray Duman; Hasan Ozkan
Journal:  Front Pediatr       Date:  2020-03-24       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.